HerAtrial.com
Title
Welcome to HERA Trial
Description
Gives details about the clinical trial involving the use of Herceptin as adjuvant therapy in HER2-positive patients with primary breast cancer. This resource is designed for use by patients and investigators.
Contact
- F.Hoffmann-La Roche AG
- Basel
- Switzerland 4070
- +41.616881148